Skip to main content
Caplight Logo









Hikma Ventures

Hikma Ventures

London, Englandhikmaventures.com

Overview

Hikma Ventures is the strategic venture capital arm of Hikma Pharmaceuticals, investing in innovative digital health and life sciences companies worldwide . They invest in disruptive technologies and companies that can make a real difference for Hikma and their portfolio companies . Their investment mandate is broad, with focus areas including drug delivery, digital therapeutics, clinical trial innovation, respiratory, CNS, oncology, and certain autoimmune and chronic diseases .

Year Founded

2015

Portfolio Companies

17

Investments

Hikma Ventures investments
CompanyDateStageLead
BiolinqApr 2025Series CCo-investor
Click TherapeuticsOct 2021Series BCo-investor
Scipher MedicineFeb 2022Series D-
Prognos HealthMay 2023Growth EquityCo-investor
O7 TherapyApr 2022SeedLead
Book a demo to see all 17 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Hikma Ventures based?

Hikma Ventures is headquartered in London, England, United Kingdom.

When was Hikma Ventures founded?

Hikma Ventures was founded in 2015.

How many portfolio companies does Hikma Ventures have?

Hikma Ventures has 17 portfolio companies in Caplight's dataset.

What are some companies in Hikma Ventures's portfolio?

Portfolio companies visible on Caplight include Biolinq, Click Therapeutics, Scipher Medicine, Prognos Health, O7 Therapy.

What was Hikma Ventures's most recent investment shown here?

Hikma Ventures's most recent investment in this portfolio sample was in Biolinq in 2025.

What sectors does Hikma Ventures focus on?

Hikma Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, Media, Entertainment & Gaming, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software.

What company stages does Hikma Ventures focus on?

Hikma Ventures typically invests at the MultiStage stage.

What is Hikma Ventures's AUM?

Hikma Ventures's assets under management are estimated between $100.0M and $250.0M.

Firmographic Details

HeadquartersLondon, England
Year Founded2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?